Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The objective of this dose-escalation study is to evaluate the safety, tolerability and
efficacy of AMA0076 in reduction of intraocular pressure in subjects with ocular hypertension
or primary open-angle glaucoma.